The present invention relates to a [1,2,4]triazolo[1,5-c]pyrimidine derivative represented by formula (I) or a pharmaceutically acceptable salt thereof, wherein R1 represents a substituted or unsubstituted aryl group Or substituted or unsubstituted aromatic heterocyclic group, R2 represents hydrogen atom, halogen, substituted or unsubstituted lower alkyl group, substituted or unsubstituted aryl group or substituted or unsubstituted aromatic heterocyclic group, na and nb are the same or different, represent an integer of 0-4, Q represents a hydrogen atom or 3,4-dimethoxybenzyl, R6 represents a hydrogen atom, a substituted or unsubstituted lower alkyl group, a halogen atom or a hydroxyl group, R3 Represents: ①hydroxyl, ②hydroxyl lower alkyl, ③substituted or unsubstituted lower alkoxy, or ④selected from substituted or unsubstituted imidazo[1,2-a]pyridyl, imidazo[1,2- a]pyrazinyl, imidazo[1,2-a]pyrimidinyl, benzimidazolyl, benzothiazolyl, benzo-2,1,3-thiadiazolyl, isoxazolyl and 3-oxo Substituted-3,4-dihydro-2H-benzo[1,4]oxazine group, when R3 represents hydroxyl, hydroxyl lower alkyl or substituted or unsubstituted lower alkoxy, R4 and R5 are The same or different, represent substituted or unsubstituted lower alkyl or substituted or unsubstituted aryl, or R4 and R5 together with adjacent carbon atoms form a substituted or unsubstituted saturated carbocyclic ring, R3 represents selected from substituted or Unsubstituted imidazo[1,2-a]pyridyl, imidazo[1,2-a]pyrazinyl, imidazo[1,2-a]pyrimidinyl, benzimidazolyl, benzothiazolyl, In the case of benzo-2,1,3-thiadiazolyl, isoxazolyl and 3-oxo-3,4-dihydro-2H-benzo[1,4]oxazinyl, R4 The same as or different from R5, represents a hydrogen atom, a substituted or unsubstituted lower alkyl group or a substituted or unsubstituted aryl group, or R4 and R5 together with adjacent carbon atoms form a substituted or unsubstituted saturated carbocyclic ring.